GenMont Biotech Incorporation announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was TWD 91.088 million compared to TWD 96.115 million a year ago. Operating income was TWD 25.563 million compared to TWD 27.385 million a year ago. Net income was TWD 41.161 million compared to TWD 4.054 million a year ago. Basic earnings per share from continuing operations was TWD 0.46 compared to TWD 0.31 a year ago. Basic earnings per share was TWD 0.46 compared to TWD 0.05 a year ago.